Veteran activist Irene Fernandez dies of heart failure
The Sun Daily
PETALING JAYA: Human rights activist and Tenaganita director Irene Fernandez (pix) died today after suffering a heart attack. Irene, 68, was admitted to the Serdang Hospital last Tuesday, after complaining of breathing difficulties while on her way to …
Tenaganita’;s Irene Fernandez dies of heart failureMSN Malaysia News
Tenaganita’s Irene Fernandez diesThe Malay Mail Online
Activist Irene Fernandez diesThe Star Online
The Borneo Post –Malaysia Kini
all 18 news articles »

University of Pittsburgh researchers get $7.3M grant to study heart failure …
Tribune-Review
Researchers at the University of Pittsburgh have received a $7.3 million federal grant over five years to study the impact of treating heart failure and depression in patients with both conditions. “It’s an approach that has not been really tried …

AstraZeneca, Shenzhen Uni To Study Chronic Kidney Disease
Asian Scientist Magazine
AsianScientist (Mar. 31, 2014) – AstraZeneca will collaborate with Shenzhen University Health Science Center to conduct pre-clinical research on chronic kidney disease, a large and growing unmet medical need in China. Under the terms of the agreement, …

Heart Failure Patients Live Longer With Advanced Devices
Bloomberg
Patients with mild heart failure live longer if they’re treated with advanced defibrillators that synchronize the beating of the heart in addition to shocking it back into rhythm when it stops, a study found. The trial, presented today at the American …
Sheba Medical Center team heads important heart failure researchJerusalem Post
Device Saves Lives in Heart Failure PatientsUniversity of Rochester Newsroom
New Long-term Data Demonstrate Patients with Mild Heart Failure Sustained …PR Newswire (press release)

all 10 news articles »

ARB, ACE inhibitor at discharge curb heart failure readmissions
Family Practice News Digital Network
WASHINGTON – Patients with acute heart failure who were discharged on an angiotensin converting enzyme inhibitor or an angiotensin receptor blocker were significantly less likely to be readmitted to the hospital within 30 days of discharge than …

Old, reliable drugs cut heart failure readmissions
Family Practice News Digital Network
WASHINGTON, D.C. – Heart failure patients discharged on inexpensive, guideline-recommended drugs were half as likely to be readmitted for the condition after 30 days, compared with those who weren’t given the drugs, according to a study of the Alabama …

and more »

New Long-term Data Demonstrate Patients with Mild Heart Failure Sustained …
PR Newswire (press release)
NATICK, Mass., March 30, 2014 /PRNewswire/ — In the longest follow-up to date of cardiac resynchronization therapy (CRT) for mild heart failure patients, Boston Scientific Corporation’s (NYSE: BSX) exclusively sponsored and landmark Multicenter …
Device Saves Lives in Heart Failure PatientsUniversity of Rochester Newsroom
Sheba Medical Center team heads important heart failure researchJerusalem Post
Survival Benefit Found After Long-Term Resynchronization TherapyForbes

all 6 news articles »

US FDA advisory committee rejects approval of Novartis’ heart failure drug …
pharmabiz.com
The US Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) voted against approval of Novartis’ RLX030 (serelaxin) for the treatment of acute heart failure (AHF). Data presented at advisory committee meeting …

Amgen expands trial of Cytokinetics heart failure drug
San Francisco Business Times (blog)
The goal of the trial is to study omecamtiv mecarbil’s safety, tolerability and pharmacokinetics — or how the body reacts to the drug — in patients with heart failure and left ventricular systolic dysfunction. Patients in the 20-week trial over about …
Cytokinetics Announces the Opening to Enrollment of the Expansion of COSMIC …ACN Newswire (press release)

all 5 news articles »